Illumina and Qiagen Enter 15-Year Diagnostics Partnership
Two leaders in genomics and molecular analysis, Illumina and QIAGEN, have announced a 15-year partnership that the companies say is aimed at increasing the...
UTC/RenRX, 3 Principals Agree to Pay $42.6M to Settle False Claims Allegations
UTC Laboratories—also known as Renaissance RX (RenRX)—and its three principals have agreed to pay a combined $42.6 million to settle federal allegations that they...
Single-Cell Transcriptional Analysis Predicts Melanoma Drug Response
Investigators at the Moffitt Cancer Center’s Donald A. Adam Melanoma and Skin Cancer Center of Excellence have just released findings from a new study...
Sequencing Method that Maps Breast Cell Differentiation Provides Insight to Cancer Development
Salk Institute researchers have used of a state-of-the-art technology known as single-nucleus (sn) assay for transposase-accessible chromatin (ATAC) sequencing (snATAC-seq) to profile how specific...
![Centogene’s CentoMD® rare disease variant database will be integrated into Qiagen’s bioinformatics suite in a rare disease bioinformatics collaboration by the companies. [Source: alengo/Getty]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1291-218x150.jpeg "NIH Commits $38M to Rare Disease Research and Affiliated Data Center")
NIH Commits $38M to Rare Disease Research and Affiliated Data Center
About $31 million in grants has been awarded by The National Institutes of Health in fiscal year 2019 to 20 teams in order to...
8 Companion Diagnostic Developers Making a Mark
If companion diagnostics (CDx) were people, they would be old enough to drink. The first CDx won FDA approval in 1998, when Dako Denmark...
Takeda, Prometheus Enter IBD Drug-Companion Diagnostic Partnership
Prometheus Biosciences said its bioinformatics platform and advanced machine learning techniques will be used by Takeda Pharmaceutical as part of a global collaboration to...
![Verge Genomics has raised $32 million in Series A financing toward further development of new treatments by combining machine learning and neuroscience with experimental biology. [Source: kentoh/Getty Images]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1787-218x150.jpeg "Novartis, with Assist from Microsoft, Launches AI Innovation Lab")
Novartis, with Assist from Microsoft, Launches AI Innovation Lab
Novartis will establish an “AI innovation lab” designed to enable its research and commercial employees to use Microsoft’s artificial intelligence solutions across operations, with...
Actionable Type 2 Diabetes Risks Uncovered
More than 67 actionable clinical discoveries were made through deep longitudinal genomic analysis by a group led by Michael Snyder, MD, chair of the...
Point-of-Care Testing Revs Up
A host of new technologies and tests are allowing faster diagnosis and improved patient care across a range of conditions
